Table 3.
Case details and characteristics of capsule closure for all included studies
| Study | LOE∗ | N∗ | Portals∗ | Capsulotomy∗ | # of suture∗ | Absorbability |
|---|---|---|---|---|---|---|
| Larson, 2015 | III | 231 | NR | IP | 3-5 | NR |
| Nawabi, 2016 | III | 177 | AL/MA/DALA | T-type | 5-6 | Nonabsorbable |
| Chandrasekaran, 2017 | IV | 55 | AL/Ant/DALA | IP | 4-6 | Absorbable |
| Cvetanovich, 2018 | III | 414 | AL/MA/DALA | T-type | 3 (vertical), 2-3 (transverse) | Absorbable |
| Hatakeyama, 2018 | III | 45 | AL/MA | IP | 2-3 | NR |
| Strickland, 2018 | I | 15 | AL/MA | IP | 2-3 | Absorbable |
| Atzmon, 2019 | II | 64 | AL/MA | IP | 2 | Absorbable |
| Chahla, 2019 | III | 634 | AL/mMA | T-type | 2-4 (vertical) | NR |
| Stone, 2019 | III | 125 | AL/mMA/DALA | T-type | 3 (vertical), 2 (transverse) | NR |
| Filan, 2020 | III | 966 | AL/mMA | T-type | 1-4 | Nonabsorbable |
| Mas Martinez, 2020 | III | 60 | AL/MA/DALA | T-type | 2-3 (vertical), 2 (transverse) | NR |
| McGovern, 2021 | III | 68 | AL/MA | IP | 1-2 | Absorbable |
| Yin, 2021 | III | 56 | NR | IP/T-type | 2-3 | NR |
| Beals, 2022 | IV | 38 | AL/MA | IP | 3 | Absorbable |
| Bech, 2022 | III | 29 | NR | IP | 2-3 | NR |
| Cong, 2022 | IV | 22 | AL/MA/DALA | Ext longitudinal | 2-3 | Nonabsorbable |
| Jimenez, 2022 | III | 84 | AL/mMA/DALA | IP | 4-6 | Absorbable |
| Gao, 2022 | IV | 194 | AL/MA | IP | 2-3 | Nonabsorbable |
AL, anterolateral; MA, mid anterior; mMA, modified mid anterior; DALA, distal anterolateral accessory; IP, interportal; ext longitudinal, extended longitudinal; # suture, the number of sutures reported for capsule closure; NR, not reported.
∗
N - sample size.